Immune Monitor September 2026

posted 13 days ago
A Message from the President With Dr. James Gulley on sabbatical this month, I’m excited to pen my first President’s Message for the monthly Immune Monitor. Dr. Gulley will be back in October. It has been an exciting ...
0 comments

Now Published: SITC Acute Leukemia CPG v2.0

posted 14 days ago
SITC is pleased to announce the publication of the guideline, “ Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia, version 2.0 ” in the Journal ...
0 comments

JITC Digest September 2026 - JITC Award Winners Announced

posted 21 days ago
JITC Digest – September 2026 In This Issue: Letter from the Editor | JITC Editor Picks | Popular Articles Hello JITC Readers, Many of us in the Northern Hemisphere have settled back into ...
0 comments

Immune Monitor August 2026 - Special Interest Groups

posted 08-24-2026
A Message from the President One of the most exciting aspects of our field is seeing how advances in cancer immunotherapy continue to translate into new possibilities for patients. Recent preliminary results with ...
0 comments

JITC Digest August 2026

posted 08-20-2026
JITC Digest – August 2026 In This Issue: Letter from the Editor | JITC Editor Picks | Popular Articles Hello JITC Readers, How time flies and the summer abates! I would like ...
0 comments

SITC Announces 2026 Class of Fellows to the Academy of Immuno-Oncology

posted 08-17-2026
The Society for Immunotherapy of Cancer (SITC) is proud to announce the 2026 Class of Fellows of the Academy of Immuno-Oncology (FAIO) , recognizing internationally renowned leaders whose pioneering discoveries and enduring ...
0 comments

Society for Immunotherapy of Cancer Forward Fund Announces 2026 Fellowship Recipients, Awarding $150,000 to Support the Next Generation of Cancer Immunotherapy Researchers

posted 08-10-2026
Reinforcing its commitment to advancing cancer immunotherapy through research and education, the Society for Immunotherapy of Cancer (SITC) Forward Fund is pleased to announce the recipients of its 2026 fellowships. This ...
0 comments

Society for Immunotherapy of Cancer Announces 2026 Annual Award Recipients

posted 08-03-2026
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the recipients of its 2026 Annual Awards, recognizing individuals whose exceptional leadership, scientific achievements and service have helped advance ...
0 comments

Immune Monitor - July 2026

posted 07-29-2026
A Message from the President As cancer immunotherapy continues to transform patient care, the next era of innovation will depend on our collective ability to develop the therapies that will define the future of the ...
0 comments

SITC Announces EU Immuno-oncology Drug Development Summit - Bringing the European IO Community Together to Foster the Next Wave of IO Therapeutics

posted 07-22-2026
Keynote Address featuring Dr. E. John Wherry – “Intersection of IO and Autoimmunity” MILWAUKEE, WI – The Society for Immunotherapy of Cancer (SITC) is proud to announce the upcoming EU Immuno-oncology Drug Development ...
0 comments

SITC and CRI Launch Annual Collaboration Bringing the Prestigious CRI William B. Coley Award Lecture to the SITC Annual Meeting

posted 07-21-2026
NK cell pioneer Éric Vivier, DVM, PhD, to deliver the inaugural lecture at SITC 2026 MILWAUKEE, WI – The Society for Immunotherapy of Cancer (SITC) and t he Cancer Research Institute (CRI) are proud to announce the ...
0 comments

JITC Digest July 2026

posted 07-15-2026
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks|New Special Series Myeloid Cells in Immuno-Oncology| JITC Meet-the-Editor Seession at JACI (Japan)| Popular Articles Letter from the Editor ...
0 comments

Oncology News Burst from the FDA: FDA Approves Pembrolizumab or Pembrolizumab and Berahyaluronidase Alfa-pmph Each with Enfortumab Vedotin-ejfv for Muscle Invasive Bladder Cancer

posted 07-13-2026
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will periodically distribute information about newly approved therapies for cancer patients. This helps the FDA inform oncologists ...
0 comments

SITC Raises Concerns About Proposed Changes to Federal Grant-Making Rules

posted 07-07-2026
The Society for Immunotherapy of Cancer (SITC) has submitted comments to the Office of Management and Budget (OMB) regarding proposed changes to the regulations governing Federal Financial Assistance . View the comments ...
0 comments

Oncology News Burst from the FDA: FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor Hematopoietic Stem Cell Transplantation for Adults with Hematologic Malignancies

posted 07-01-2026
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will periodically distribute information about newly approved therapies for cancer patients. This helps the FDA inform oncologists ...
0 comments

Immune Monitor - June 2026

posted 07-01-2026
A Message from the President As Cancer Immunotherapy Awareness Month comes to a close, I’m reflecting on the remarkable progress and momentum in the field of cancer immuno-oncology. Throughout June, our community celebrated ...
0 comments

Oncology News Burst from the FDA: FDA Approves Sacituzumab Govitecan-hziy as Monotherapy and in Combination with Pembrolizumab for First-Line Treatment of Triple-Negative Breast Cancer

posted 06-30-2026
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will periodically distribute information about newly approved therapies for cancer patients. This helps the FDA inform oncologists ...
0 comments

Oncology News Burst from the FDA: FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of renal cell carcinoma

posted 06-29-2026
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will periodically distribute information about newly approved therapies for cancer patients. This helps the FDA inform oncologists ...
0 comments

JITC Digest June 2026

posted 06-17-2026
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks|SITC 40 th Anniversary Special Series| Popular Articles Letter from the Editor Hello JITC Readers, June is ...
0 comments

2026 ASCO Annual Meeting Scientific Highlights - June 2

posted 06-03-2026
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, June 2, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific ...
0 comments

Back to SITC Cancer Immunotherapy Guidelines